Ownership history in VR Adviser, LLC · 9 quarters on record
This page tracks every 13F SEC filing in which VR Adviser, LLC reported a position in SPYRE THERAPEUTICS INC (SYRE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 3,685,448 | +1,000,000 | +37.2% | 5.96% | $120.7M | $32.76 |
| 2025 Q3 | UNCHANGED | 2,685,448 | — | 0% | 2.53% | $45.0M | $16.76 |
| 2025 Q2 | UNCHANGED | 2,685,448 | — | 0% | 3.01% | $40.2M | $14.97 |
| 2025 Q1 | UNCHANGED | 2,685,448 | — | 0% | 3.69% | $43.3M | $16.14 |
| 2024 Q4 | UNCHANGED | 2,685,448 | — | 0% | 4.29% | $62.5M | $23.28 |
| 2024 Q3 | UNCHANGED | 2,685,448 | — | 0% | 4.14% | $79.0M | $29.41 |
| 2024 Q2 | ADDED | 2,685,448 | +513,666 | +23.7% | 4.02% | $63.1M | $23.51 |
| 2024 Q1 | REDUCED | 2,171,782 | -200,932 | -8.5% | 3.92% | $82.4M | $37.93 |
| 2023 Q4 | INITIATED | 2,372,714 | — | — | 3.50% | $51.1M | — |
As of 2025 Q4 — sorted by position size